Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Bortezomib chemotherapy can cause temporary skin rashes.

Prostaglandins may protect hair follicles during chemotherapy.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Pantethine may boost the immune system's ability to fight sarcoma.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Metformin may help treat neuroendocrine tumors.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.